中国P站

Gut Microbiome; Immune System; Microbial Metabolites; Dendritic Cells; T Cells; Immune Tolerance; Inflammatory Bowel Disease; Cancer Immunotherapy; Gut-Brain Axis; Fecal Microbiota Transplantation

Introduction

The intricate bidirectional communication between the gut microbiome and the host immune system is a cornerstone of physiological well-being, profoundly influencing both local intestinal immunity and systemic immune responses [1].

Microbial metabolites, such as short-chain fatty acids, play a crucial role in modulating immune cell development, differentiation, and overall function, impacting the delicate balance of immune tolerance [1].

The gut microbiome also acts as a critical interface with the adaptive immune system, with specific bacterial species and their metabolites capable of modulating dendritic cell function [2].

These commensal bacteria can prime dendritic cells to promote the differentiation of T regulatory cells, thereby maintaining immune homeostasis and preventing excessive inflammation [2].

Furthermore, the composition of the gut microbiota has emerged as a significant factor in the efficacy of cancer immunotherapy, particularly with checkpoint inhibitors [3].

Emerging research suggests that the gut microbiome can influence patient responses to these life-saving therapies, indicating that microbial interventions may hold promise for enhancing treatment outcomes [3].

The gut microbiome's influence extends to the development and function of the adaptive immune system, with a particular emphasis on T cells [4].

Microbial antigens and metabolites are key regulators in shaping T cell polarization, including the induction of critical cell types like Th17 and regulatory T cells, which are essential for maintaining gut immunity and preventing autoimmune conditions [4].

Early-life colonization by the gut microbiome is pivotal for immune system development, with lasting consequences for long-term immune health [5].

Microbial colonization during infancy primes the developing immune system, thereby influencing an individual's susceptibility to allergies and autoimmune diseases later in life, highlighting a critical window for establishing a healthy microbiome [5].

Alterations in microbial composition and function are intrinsically linked to the pathogenesis of inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis [6].

This complex interplay between the gut microbiome and IBD influences intestinal barrier integrity and the intricate immune cell responses occurring within the gut environment [6].

The gut microbiome also exerts a significant influence on brain function and behavior through the gut-brain axis, a complex communication network [7].

Microbial metabolites and products can directly signal to the central nervous system, impacting mood, cognition, and even susceptibility to neurological disorders, with the immune system often serving as a key mediator in this crosstalk [7].

Specific microbial metabolites, such as indole derivatives, have been identified as potent modulators of immune responses [8].

These compounds can engage with signaling pathways like the aryl hydrocarbon receptor (AhR) to regulate immune cell activation and cytokine production, offering potential avenues for targeted immune modulation via microbiome-based strategies [8].

Restoring a healthy microbial community, for instance, through fecal microbiota transplantation (FMT), can effectively re-educate the immune system [9].

This therapeutic approach has demonstrated efficacy in conditions such as recurrent Clostridioides difficile infection, leading to improved immune responses and successful disease resolution by re-establishing a balanced microbial ecosystem [9].

Germ-free animal models have been instrumental in dissecting the intricate mechanisms underlying host-microbe interactions, particularly concerning the microbiome's contributions to immune development and function [10].

These models provide critical insights into the precise ways in which specific microbial components and entire communities orchestrate host immunity and influence the complex crosstalk between the microbiome and the immune system [10].

Description

The gut microbiome's extensive influence on the host immune system involves a sophisticated bidirectional communication network, impacting both local intestinal immunity and systemic responses [1].

Microbial metabolites, including short-chain fatty acids (SCFAs), are key players in this interaction, shaping the development, differentiation, and functional capacity of immune cells, and thereby influencing immune tolerance and the progression of immune-mediated diseases [1].

Dendritic cells (DCs) serve as crucial sentinels at the interface between the gut microbiota and the adaptive immune system, with their function being significantly modulated by specific bacterial species and their metabolic products [2].

Commensal bacteria can induce DCs to promote the differentiation of regulatory T cells, a process vital for maintaining immune homeostasis and preventing aberrant inflammatory responses [2].

The composition of the gut microbiota is increasingly recognized as a critical determinant of therapeutic efficacy in cancer immunotherapy, particularly in the context of checkpoint inhibitors [3].

This research indicates that the gut microbial landscape can profoundly affect patient responses to these treatments, suggesting a potential role for microbiome-targeted interventions in optimizing therapeutic outcomes [3].

The development and function of the adaptive immune system, especially T cell subsets, are significantly shaped by the gut microbiome [4].

Microbial antigens and metabolites play a direct role in directing T cell polarization, facilitating the induction of key T cell populations such as Th17 and regulatory T cells, which are essential for maintaining intestinal immune balance and preventing autoimmune disorders [4].

Early-life immune development is profoundly influenced by the gut microbiome, with critical implications for lifelong immune health [5].

The microbial colonization that occurs during infancy primes the immune system, thereby affecting an individual's predisposition to allergies and autoimmune diseases later in life, underscoring the importance of establishing a healthy microbiome during this sensitive period [5].

Alterations in the gut microbiome's composition and function are central to the pathogenesis of inflammatory bowel diseases (IBD) [6].

Dysbiosis contributes to the development of Crohn's disease and ulcerative colitis by impacting intestinal barrier integrity and modulating immune cell responses within the gut, highlighting the microbiome's role in gut inflammation [6].

The gut microbiome plays a significant role in modulating brain function and behavior through the gut-brain axis [7].

Microbial-derived metabolites and products can influence the central nervous system, affecting mood, cognition, and susceptibility to neurological conditions, with the immune system acting as an important mediator in this complex crosstalk [7].

Specific microbial metabolites, such as indole derivatives, possess the ability to modulate immune responses by interacting with cellular signaling pathways like the aryl hydrocarbon receptor (AhR) [8].

This interaction can regulate immune cell activation and the production of cytokines, offering a mechanism for targeted immune modulation through microbiome-derived compounds [8].

Restoring a balanced microbial community through interventions like fecal microbiota transplantation (FMT) can effectively recondition the immune system [9].

This approach has shown significant success in treating conditions such as recurrent Clostridioides difficile infection by improving immune function and resolving the disease through the re-establishment of a healthy microbial ecosystem [9].

Germ-free animal models have been indispensable in elucidating the intricate mechanisms of host-microbe interactions and the microbiome's role in immune development and function [10].

These models allow for the precise dissection of how specific microbial components and communities contribute to immune regulation and the broader crosstalk between the gut microbiome and the host immune system [10].

Conclusion

The gut microbiome plays a critical role in modulating the host immune system, influencing everything from immune cell development and tolerance to susceptibility to inflammatory diseases and response to cancer immunotherapies. Microbial metabolites, such as SCFAs and indole derivatives, are key signaling molecules that impact immune cell function and polarization. The gut-brain axis is also affected by the microbiome, influencing neurological health. Early-life microbial colonization is crucial for long-term immune programming. Fecal microbiota transplantation (FMT) demonstrates the power of restoring a healthy microbiome to re-educate the immune system. Germ-free animal models have been vital in understanding these complex interactions.

References

1. Clarysse, J, Van GJA, Migeotte, I. (2021) .Immunol Rev 302:204-227.

   , ,

2. Rescigno, M, Manfredo, G, Trompette, A. (2018) .Cell Host & Microbe 23:170-182.

   , ,

3. Routy, J, Le CE, Derosa, L. (2018) .Nat Rev Clin Oncol 15:352-367.

   , ,

4. Lee, SM, Gallardo, CD, Beller, DI. (2019) .Immunity 50:627-637.

   , ,

5. Russell, SL, Chandrakanth, R, Thompson, JS. (2020) .Annu Rev Immunol 38:349-373.

   , ,

6. Kroneman, T, Tan, J, Belzer, C. (2019) .Gastroenterology 156:439-450.

   , ,

7. Cryan, JF, O'Riordan, KJ, Sandhu, KV. (2019) .Nat Rev Neurosci 20:596-608.

   , ,

8. Kiss, E, Mori, Y, Fujimura, K. (2018) .Science 362:231-236.

   , ,

9. van NE, Vrieze, A, Holleman, F. (2013) .N Engl J Med 369:407-415.

   , ,

10. Thaiss, CA, Zeller, G, Scharf, C. (2016) .J Immunol 196:1553-1561.

    , ,